Showing results (91-100 of 1,273) with videos related to
Sort By:
Pageof 128
Clinical Colorectal Cancer|September 2, 2006
Oxaliplatin-associated hypersensitivity reactions: clinical presentation and managementMaureen R Hewitt, Weijing SunClinical Colorectal Cancer|September 2, 2006
Role of panitumumab in the management of metastatic colorectal cancerMohammad Wasif Saif, Michael CohenuramClinical Colorectal Cancer|September 2, 2006
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancerMichael J O'Connell, Daniel J Sargent, Harold E Windschitl, et al.Clinical Colorectal Cancer|September 2, 2006
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicityPaul L Mitchell, David Goldstein, Michael Michael, et al.Clinical Colorectal Cancer|June 3, 2005
The rTS signaling pathway as a target for drug developmentBruce J DolnickClinical Colorectal Cancer|June 3, 2005
Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphismRanee Mehra, John Murren, Gina Chung, et al.Clinical Colorectal Cancer|June 6, 2022
Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized TrialJuliana Ominelli, Rodrigo O de Castro Araujo, Marcus Valadão, et al.Clinical Colorectal Cancer|June 26, 2022
Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal CanalIara K F Lustosa, Marcos P G Camandaroba, Bruna R S Mattos, et al.Clinical Colorectal Cancer|December 18, 2022
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal CancerTony R Reid, Nacer Abrouk, Scott Caroen, et al.Clinical Colorectal Cancer|December 6, 2022
Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching AnalysisHuaqiang Ouyang, Weidong Ma, Tongguo Si, et al.Pageof 128